Upregulated programmed death ligand 1 expression in nivolumab-induced lichen nitidus: A follow-up report with an immunohistochemical analysis

J Dermatol. 2020 Sep;47(9):e319-e320. doi: 10.1111/1346-8138.15480. Epub 2020 Jul 8.

Authors

Takayoshi Komatsu-Fujii^{1

2}, Saeko Nakajima¹, Masashi Iwata¹, Tatsuki Kataoka³, Masahiro Hirata³, Takashi Nomura¹, Kenji Kabashima^{1

4}

Affiliations

¹ Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
² Department of Dermatology, Tenri Hospital, Tenri, Japan.
³ Department of Diagnostic Pathology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
⁴ Agency for Science, Technology and Research (A*STAR), Singapore Immunology Network (SIgN) and Skin Research Institute of Singapore (SRIS), Singapore, Singapore.

PMID: 32643192
DOI: 10.1111/1346-8138.15480

No abstract available

Publication types

Letter

MeSH terms

B7-H1 Antigen
Follow-Up Studies
Humans
Lichen Nitidus* / chemically induced
Lichen Nitidus* / diagnosis
Lichen Nitidus* / drug therapy
Nivolumab* / adverse effects

Substances

B7-H1 Antigen
Nivolumab